About CHAOJU EYE CARE Company

The Group is a leading ophthalmology medical service group in North China and a nationally renowned ophthalmology medical service group. The Group was founded in Baotou, Inner Mongolia in 1988 to provide an ophthalmology service clinic. The Group will continue to adhere to the vision of “becoming a global leader in happy eye health” in the new decade, providing patients with a safe, secure and happy ophthalmology medical environment through effective medical equipment technology and professional and caring humanized services. The Group's revenue mainly comes from (i) consumer ophthalmology services and (ii) basic ophthalmology services. Consumer ophthalmology services include treatment and prevention of various kinds of ophthalmic abnormalities, including refractive correction (including presbyopia correction), prevention and control of myopia, dry eye, eye surgery, and provision of optometry products and services. The costs of such services are currently not covered by public health insurance plans. Basic ophthalmology services include treatments for various common ophthalmic diseases such as cataracts, glaucoma, strabismus, fundus disease, surface eye diseases, orbital diseases, and pediatric eye diseases, which are generally eligible for public health insurance plans. In view of the increase in consumer demand in China in recent years, the Group plans to focus more strategically on the consumer ophthalmology service business while maintaining its basic advantages in the basic ophthalmology business, and invest more energy to continue its rapid growth. The Group's patients are treated by ophthalmologists equipped with advanced technology and equipment. The Group's medical team consists of ophthalmologists who are proficient in various eye diseases. They have deep medical backgrounds and rich experience. Advanced technology and equipment are another key factor in consolidating market leadership. Baotou Hospital is the only ophthalmology hospital in Inner Mongolia with a preparation room. It produces homemade traditional Chinese medicine capsules and eye drops. The Group believes that its ability to make homemade medicines will help it enhance brand awareness and customer loyalty, thereby bringing the Group a competitive advantage and increasing overall benefits in myopia prevention and control. The Group believes that the following competitive advantages can differentiate it from its competitors: As a leading ophthalmology medical service group in China, the Group is in an advantageous position in the industry to grasp the huge demand in the broad market for ophthalmology services. The Group's clustered operation model helps improve market penetration, operating efficiency and profitability. The Group's centralized and standardized management system enables the business model to be expanded and replicated. The Group has a high-level medical professional team and a perfect personnel training system, which is the foundation for its development. The Group creates excellent customer satisfaction with comprehensive, full-process clinical ophthalmology treatment services. The Group has received strong support from an experienced management team and shareholders.